Cystex Tablet
Product Images NDC 69693-518

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cystex (NDC 69693-518). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Clarion Brands, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton (Cystex Dual Action 24ct)

Cystex Pain Relief tablets with methenamine 162 mg and sodium salicylate 162.5 mg (NSAID) for urinary health and UTI bacteria control. The label highlights a 2-in-1 formula to help slow UTI bacterial growth and provide general pain relief. The package contains 24 oral tablets and is labeled by Clarion Brands, LLC. The label includes drug facts, warnings, directions, and other information on the back panel.*

FDA Label Image

48 Tablets (Cystex Dual Action 48ct)

Cystex Oral Tablets packaging label for urinary health by Clarion Brands, LLC. Each tablet contains methenamine 162 mg and sodium salicylate 162.5 mg (NSAID). The label highlights dual action for pain relief and UTI bacterial control, indicating a 2-in-1 formula to reduce UTI bacteria growth and provide general pain relief. The package contains 48 tablets.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.